BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19243541)

  • 1. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients.
    Schonewille H; de Vries RR; Brand A
    Transfusion; 2009 Mar; 49(3):453-7. PubMed ID: 19243541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
    Schonewille H; van de Watering LM; Brand A
    Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloimmunization to red cell antigens in liver and multivisceral transplant patients.
    Shariatmadar S; Pyrsopoulos NT; Vincek V; Noto TA; Tzakis AG
    Transplantation; 2007 Aug; 84(4):527-31. PubMed ID: 17713438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.
    Schonewille H; Brand A
    Br J Haematol; 2005 Apr; 129(1):151-6. PubMed ID: 15801967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
    Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
    Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alloimmunization in polytransfused patients. Usefulness of selecting erythrocytes compatible with antigens different from ABO and D].
    García Gala JM; Vargas Pabon M; Rodríguez Vicente P; Ramírez Payer A; Rosón Porto C; Corte Buelga JR
    Sangre (Barc); 1994 Dec; 39(6):417-21. PubMed ID: 7855692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of anti-D in D- recipients transfused with D+ red blood cells.
    Yazer MH; Triulzi DJ
    Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA; Fisk J; Stack G
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H; Brand A
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
    Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
    Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis.
    Shukla JS; Chaudhary RK
    Indian J Pathol Microbiol; 1999 Jul; 42(3):299-302. PubMed ID: 10862287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.
    Schonewille H; van de Watering LM; Loomans DS; Brand A
    Transfusion; 2006 Feb; 46(2):250-6. PubMed ID: 16441603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
    McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD
    Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.
    Ribeiro KR; Guarnieri MH; da Costa DC; Costa FF; Pellegrino J; Castilho L
    Vox Sang; 2009 Aug; 97(2):147-52. PubMed ID: 19392786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis].
    Arriaga F; Bonanad S; Larrea L; de la Rubia J; López F; Sanz MA; Sanz G; Marty ML
    Sangre (Barc); 1995 Jun; 40(3):177-80. PubMed ID: 7570268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red-blood-cell alloimmunization and number of red-blood-cell transfusions.
    Zalpuri S; Zwaginga JJ; le Cessie S; Elshuis J; Schonewille H; van der Bom JG
    Vox Sang; 2012 Feb; 102(2):144-9. PubMed ID: 21729098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.